1. Home
  2. MLCO vs AVDL Comparison

MLCO vs AVDL Comparison

Compare MLCO & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$6.31

Market Cap

2.5B

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.63

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCO
AVDL
Founded
2004
2015
Country
Hong Kong
Ireland
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
MLCO
AVDL
Price
$6.31
$21.63
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$9.42
$19.14
AVG Volume (30 Days)
2.7M
1.5M
Earning Date
02-12-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$5,061,044,000.00
$248,517,000.00
Revenue This Year
$13.28
$65.47
Revenue Next Year
$2.61
$30.88
P/E Ratio
$25.06
N/A
Revenue Growth
11.46
79.88
52 Week Low
$4.55
$6.38
52 Week High
$10.15
$23.57

Technical Indicators

Market Signals
Indicator
MLCO
AVDL
Relative Strength Index (RSI) 42.53 62.61
Support Level $5.98 $21.52
Resistance Level $6.53 $21.65
Average True Range (ATR) 0.23 0.07
MACD 0.09 -0.00
Stochastic Oscillator 65.55 73.81

Price Performance

Historical Comparison
MLCO
AVDL

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: